PH vs STRO
Parker-Hannifin Corporation (PH) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PH and STRO stock pages for the full models.
Not investment advice.